The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
Results for: 2018 Diagnosis Screening Ann Scott
Guest Speaker Dr. Chris Henshall works as an independent consultant, advising governments, public and private sector organisations on health, research and innovation policy. Chris has worked previously for the Health Promotion Research Trust, the UK Medical Research Council and the Department of Health and NHS in England. As Deputy Director of R&D for the Department and NHS, he…
Speaker Dr. Irfan Dhalla Vice-President of Evidence Development and Standards at Health Quality Ontario Health technology assessment and quality improvement have different historical and philosophical underpinnings, but people who use either approach share a common goal: better health care, and ultimately better health. The two approaches can be used together to achieve more than…
Event Details: Date: Tuesday, November 21, 2017 (dinner, November 20, 2017) Venue: Lister Conference Centre, 1-047 Lister Centre, University of AlbertaLocation: Edmonton, Alberta REGISTER HERE Subscribe to NOAHE updates
This year, APCC completes the circle with an innovative and action-driven agenda that strives for progress, not perfection. It is pushing the boundaries of primary care and concentrating on the patient's journey across the system. The IHE is pleased to be a sponsor for APCC 2017: Advancing Patient Collaborative Care where participants will be inspired to build new momentum and…
Award Date: IHE Mazankowski Awards awarded annually in January/May? Awards Available: Up to three (???) awards per institution annually Award Value: $2,000 Eligibility – University of Alberta: Recipients must be (full time? part time?) University of Alberta students registered/enrolled in Health Economics 000 Eligibility – University of Calgary: Recipients must be (full time? part…
Summary Report Summary Report Coming Soon Program IHE/CAPT Real World Evidence Workshop – Final ProgramDownload Final Program
Sunday, 21 October 2018 Toronto, Ontario 09:00 – 09:15 Welcome and Design Sprint Overview Allan GIllman 09:15 – 10:15 Lightning Talks Rhonda Kropp, Tammy Clifford, Kelvin Chan, Michael Duong 10:15 – 10:30 Break 10:30 – 10:45 Design Challenge Statement and Case Study Presentation Dan Palfrey, Senior Consultant, Institute of Health Economics 10:45 – 12:45 Identification of Applications…
Speaker Biographies Rhonda Kropp Rhonda Kropp is currently the Director General for the Marketed Health Products Directorate in the Health Products and Food Branch of Health Canada. She is responsible for the oversight of the vigilance of marketed health products in Canada, including ensuring Canadians and health professionals are informed of important issues impacting the safety…
21 October 2018 Toronto, Ontario On October 21, 2018, in conjunction with the 2018 Annual CAPT Conference, the Institute of Health Economics (IHE) and the Canadian Association for Population Therapeutics (CAPT) co-hosted the IHE/CAPT Real World Evidence Workshop. The intent of the workshop was to identify key opportunities for RWE to support decision-making throughout the pharmaceutical…
3 June 2018 Vancouver, British Columbia On June 3rd, as part of the 2018 Health Technology Assessment International (HTAi) Annual Conference in Vancouver, the Institute of Health Economics (IHE) led a panel presentation on facilitators, innovators, and innovations in chronic obstructive pulmonary disease (COPD) care in Canada. The panel Facilitating Adoption of Innovative Practices…
Facilitating innovation in the market for COPD – related services. Philip Jacobs, IHE 7/9/18 In 2016 and 2017 IHE presented two research reports on the state of the market for COPD - related services, based on research grants provided by Boehringer Ingelheim. The first report, Economic Surveillance for COPD in Alberta (available from https://www.ihe.ca/publications/economic-surveillance-for-chronic-obstructive-pulmonary-disease-copd-in-alberta),…
This clinical practice guideline and background document were produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use…
In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness of that technology for health systems, creating a comprehensive picture of how the technology is good value for money. Without this key component in an evidentiary…
Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service. The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present…
Learn how health economics and early-stage technology assessment can support your research and development planning, raise capital, and help communicate your value proposition more clearly and effectively to payers. The IHE provides Alberta small- and medium-sized enterprises (SMEs) and innovation ecosystem partners with educational services to describe the importance of, and requirements…
To learn more about the Alberta Real World Evidence (RWE) Consortium, please visit www.AlbertaRWE.ca! Evidence that captures the observed impact of a process or technology on health outcomes and resource utilization outside of controlled clinical trials (real-world evidence or RWE) is highly valuable to technology developers, manufacturers, regulators, payers, clinicians, and…
The goal of the Alberta Secondary Use Data Access (SUDA) initiative is to accelerate health research, support innovation, and strengthen the health system through insights from analysis of health data. The IHE is serving as a partner to the Government of Alberta (GOA) to strengthen analytic capacity and foster collaboration between the GOA, industry, and other contributors. The…
The IHE established its Health Technology Innovation Platform (HTIP) to enhance decision-making efficiency and improve value for money for purchasers of health technology, and to strengthen the ability for technology developers to engage in constructive policy dialogue, demonstrate the value of their technology, and improve their return on investment. The HTIP facilitates collaboration…
Community Voices: Diabetes in Indigenous Populations is a video project that aims to highlight Indigenous perspectives on health, and promote shared learning for a variety of stakeholders within the context of health, well-being, and health care in Canada. New videos from the series will be added regularly, and will highlight voices from Indigenous communities describing current…
Real World Evidence (RWE) studies investigate the impact of an intervention or technology on health outcomes and resource utilization in clinical conditions outside of the controlled clinical trial setting. The evidence is generated from routinely collected health data to evaluate the safety, effectiveness, and value of newly introduced or existing health technologies and/or other…
Showcasing Alberta Applied Research The ‘Fit for Work’ Project: Living and working well with arthritis A project supported by AbbVie and Alberta Economic Development and Trade in partnership with the Alberta Schools Employee Benefit Plan. Providing lessons for employees and employers around tools and resources to make workplaces healthy and productive. Speakers Dr. Diane Lacaille,…
In recent years, the interest and need for real-world evidence (RWE) has been increasing due to the advent of innovative, yet expensive, pharmaceutical drugs, e.g. in the context of the evidence gaps for rare diseases. Numerous initiatives are undergoing worldwide to assess the potential use of RWE in decision making on drug regulation and health technology assessment (HTA). However,…
Conferences are larger, standalone or serial events, hosted by the IHE or in partnership with other organizations. Various IHE Conferences have seen leading health care professionals from Canada and the United States come to Edmonton to discuss health care and health policy challenges. The IHE’s well-regarded Consensus Development Conference Series, which has seen us host international…
The purpose of this event is to provide a platform for shared learning and to showcase CADTH and Alberta initiatives on the creation and uptake of evidence-based guidance/direction from HTA and related processes. It will provide an opportunity for reflection from clinical leaders/practitioners on where processes are working well and on how they might be adapted to be more meaningful…
Knowledge Transfer & Dissemination Knowledge transfer and dissemination is an integral part of the IHE’s activities. As a neutral convenor for health policy dialogue and evidence development and dissemination, the IHE has a well-established role in facilitating and supporting the translation of knowledge into practice. Included in the IHE’s outreach and collaboration portfolio…
IHE Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. The IHE hosts various events of different sizes and audiences, on a wide variety of topics. Past events have included Health Policy events, the IHE Innovation Forum Series, Roundtables…
